Publication | Closed Access

Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors

Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesMedicineRational Drug DesignAntibacterial AgentDrug DevelopmentChemical BiologyPharmacologyPharmaceutical ChemistryDrug Discovery